8 TRT Myths Debunked: What the Science Actually Says
Common misconceptions about testosterone replacement therapy — roid rage, prostate cancer, heart attacks, and other myths vs. what clinical evidence shows.
Separating Fact from Fiction
TRT carries more mythology than almost any medical treatment. Decades of outdated beliefs, conflation with steroid abuse, and media sensationalism have created a minefield of misinformation. Here's what the clinical clinical safety evidence actually says.
Myth 1: "TRT causes prostate cancer"
Reality: This belief originated from a 1941 case report and has been thoroughly debunked. The TRAVERSE trial, multiple meta-analyses, and a December 2025 FDA expert panel all confirm no causal link between TRT and prostate cancer in properly screened men. The FDA panel recommended removing the prostate cancer warning from TRT labels entirely.
Myth 2: "TRT causes heart attacks"
Reality: The TRAVERSE trial (5,246 men) found no increase in heart attacks, strokes, or cardiovascular death. A VA study of 83,010 men found that normalizing testosterone was associated with 56% lower mortality. The cardiovascular scare was based on flawed studies that have been widely criticized in the medical literature.
Myth 3: "TRT is the same as steroids"
Reality: TRT restores testosterone to the normal physiological range (450-700 ng/dL) under medical supervision. Anabolic steroid abuse involves supraphysiological doses (often 500-2000+ mg/week vs. TRT's 100-200mg/week) without medical oversight. The goals, doses, and risk profiles are fundamentally different.
Myth 4: "TRT causes 'roid rage'"
Reality: Mood instability is associated with supraphysiological dosing, not therapeutic replacement. Most men on properly dosed TRT report improved mood stability, less irritability, and better emotional regulation — the opposite of rage.
Myth 5: "You'll need TRT forever once you start"
Reality: Partially true, but misleading. TRT suppresses natural production, so stopping means levels will drop. However, natural production typically recovers within 6-12 months with appropriate management. The reason most men stay on TRT isn't dependency — it's that they feel dramatically better and choose to continue.
Myth 6: "Young men don't need TRT"
Reality: While age-related decline is the most common cause, men in their 20s and 30s can have clinically low testosterone due to genetic conditions, pituitary disorders, prior steroid use, obesity, medications, or environmental factors. If labs confirm low T and symptoms are present, age doesn't disqualify treatment.
Myth 7: "TRT will make you a bodybuilder"
Reality: Therapeutic TRT restores normal levels. You'll gain some lean mass and lose some fat — but you won't look like a fitness model without dedicated training and nutrition. TRT supports muscle growth; it doesn't create it from a couch.
Myth 8: "Testosterone boosting supplements work just as well"
Reality: No over-the-counter supplement has been proven to meaningfully raise testosterone in men with clinical hypogonadism. Products containing ashwagandha, D-aspartic acid, or tribulus may produce marginal effects in men with normal T, but they cannot replace what TRT provides for men with documented deficiency.